Article info
PDFChronic obstructive pulmonary disease
Original article
Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis
- Correspondence to Dr Yuji Oba, Division of Pulmonary, Critical Care and Environmental Medicine, University of Missouri, School of Medicine, One Hospital Drive, CE 412 Columbia, MO 65212, USA; obay{at}health.missouri.edu
Citation
Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis
Publication history
- Received December 22, 2014
- Revised August 28, 2015
- Accepted September 27, 2015
- First published October 21, 2015.
Online issue publication
September 01, 2022
Article Versions
- Previous version (12 November 2019).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online table 1
- Data supplement 2 - Online table 10
- Data supplement 3 - Online table 11
- Data supplement 4 - Online table 2
- Data supplement 5 - Online table 3
- Data supplement 6 - Online table 4
- Data supplement 7 - Online table 5
- Data supplement 8 - Online table 6_8
- Data supplement 9 - Online table 9
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/